A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03517566 · TERMINATED
Trial details
- NCT number
- NCT03517566
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-14
- Primary completion
- 2020-07-15
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.